Previous Article | Next Article ![]()
Infect. Immun., 06 1997, 2112-2118, Vol 65, No. 6
SR Klee, BD Tzschaschel, I Falt, A Karnell, AA Lindberg, KN Timmis and CA Guzman
Vaccine candidates against Shigella dysenteriae type 1, which is associated
with the most severe cases of bacillary dysentery, were constructed. The
rfp and rfb gene clusters, which code for S. dysenteriae 1 O antigen
biosynthesis, were randomly integrated into either the chromosome or the
virulence plasmid of the rough attenuated Shigella flexneri aroD strain
SFL124-27 with a minitransposon carrying an arsenite resistance selection
marker. The recombinant clones efficiently expressed the recombinant O
antigen, exhibited a normal growth pattern, were able to invade and survive
within eukaryotic cells to the same extent as the parental strain, and
expressed the recombinant antigen within invaded cells. A clone was
selected as the vaccine candidate, which was demonstrated to be immunogenic
and safe in animal models, leading to 47% full protection and 53% partial
protection against challenge with the wild-type strain.
Copyright © 1997, American Society for Microbiology
Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1
Division of Microbiology, GBF-National Research Centre for Biotechnology, Braunschweig, Germany.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|